Cite

HARVARD Citation

    Khan, N. et al. (2022). Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease. Journal of Crohn's and colitis. pp. 1505-1507. [Online]. 
  
Back to record